2m 2m 2m 2m 2m 2m 2m
ONKURE THERAP-A (OKUR)
NASDAQ
$2.60+$0.02 (+0.58%)
Price as of Oct 22, 2026 7:52 PM EDT- $93.1MMarket Cap
- -13.42%1-Year Change
- BiotechnologyIndustry
ONKURE THERAP-A (OKUR)
$2.60+$0.02 (+0.58%)
OKUR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.58 | ||
Change | -$0.06 (-2.54%) | ||
Open | $2.30 | ||
High | $2.59 | ||
Low | $2.28 | ||
Previous Close | $2.30 | ||
Volume | 243,942 | ||
30-Day Average Volume | 433,052 | ||
1-Week Change | 2.22% | ||
1-Month Change | -24.84% | ||
1-Year Change | -20.69% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 40.5M | ||
Total Assets | $179.4M | ||
Market Cap | $93.1M | ||
Enterprise Value | -$73.4M | ||
Period: QTR TTM FY | |||
Revenue | $1.6M | ||
Net Income | -$15.3M | ||
Free Cash Flow | -$10.4M | ||
EBIT | -$15.3M | ||
EBITDA | -$15.3M | ||
Net Working Capital | $171.0M | ||
EPS | -$0.31 | ||
Enterprise Value/EBITDA | 5 | ||
Enterprise Value/Revenue | -47 | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | -0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue